Brenntag (FRA:BNR) has been given a €61.00 ($70.93) price objective by Commerzbank in a report released on Friday. The firm presently has a “buy” rating on the stock. Commerzbank’s target price suggests a potential upside of 29.40% from the company’s current price.
BNR has been the subject of several other research reports. UBS Group set a €60.00 ($69.77) target price on Brenntag and gave the stock a “buy” rating in a research report on Monday, September 3rd. BNP Paribas set a €64.00 ($74.42) target price on Brenntag and gave the stock a “buy” rating in a research report on Tuesday, October 2nd. Goldman Sachs Group set a €56.00 ($65.12) target price on Brenntag and gave the stock a “neutral” rating in a research report on Thursday, June 21st. Berenberg Bank set a €57.00 ($66.28) target price on Brenntag and gave the stock a “neutral” rating in a research report on Monday, September 3rd. Finally, Nord/LB set a €53.00 ($61.63) target price on Brenntag and gave the stock a “neutral” rating in a research report on Tuesday, August 28th. One analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of €58.46 ($67.98).
Shares of BNR traded down €0.25 ($0.29) during mid-day trading on Friday, hitting €47.14 ($54.81). The stock had a trading volume of 140,531 shares. Brenntag has a fifty-two week low of €43.06 ($50.07) and a fifty-two week high of €56.25 ($65.41).
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Read More: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.